(Press-News.org) Autism does not appear to be solely caused by a deficiency of oxytocin, but the hormone's universal ability to boost social function may prove useful in treating a subset of children with the developmental disorder, according to new findings from the Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford.
Low levels of oxytocin, a hormone involved in social functioning, have for years been suspected of causing autism. Prior research seeking a link has produced mixed results. Now, in the largest-ever study to test the purported connection, the range of blood oxytocin levels has been shown to be the same in children with autism as that observed in two comparison groups: children with autistic siblings and children without autistic siblings. In other words, similar numbers of children with low, medium and high oxytocin levels were found in all three groups.
A paper describing the new findings will be published online Aug. 4 in Proceedings of the National Academy of Sciences.
Although autism was not directly linked to oxytocin deficiency, the Stanford team found that higher oxytocin levels were linked to better social functioning in all groups. All children with autism have social deficits, but in the study these deficits were worst in those with the lowest blood oxytocin and mildest in those with the highest oxytocin. In the comparison groups, children's social skills also fell across a range that correlated to their oxytocin levels.
"Oxytocin appears to be a universal regulator of social functioning in humans," said Karen Parker, PhD, assistant professor of psychiatry and behavioral sciences and the lead author of the study. "That encompasses both typically developing children as well as those with the severe social deficits we see in children with autism."
Autism is a developmental disorder that affects 1 of every 68 children in the United States. It is characterized by social and communication deficits, repetitive behaviors and sensory problems. The new study included 79 children with autism, 52 of their unaffected siblings and 62 unrelated children without autism. All of the children were between the ages of 3 and 12.
"It didn't matter if you were a typically developing child, a sibling or an individual with autism: Your social ability was related to a certain extent to your oxytocin levels, which is very different from what people have speculated," said Antonio Hardan, MD, professor of psychiatry and behavioral sciences and the study's senior author. Hardan is a child and adolescent psychiatrist who treats children with autism at the hospital.
"The previous hypotheses saying that low oxytocin was linked to autism were maybe a little bit simplistic," he said. "It's much more complex: Oxytocin is a vulnerability factor that has to be accounted for, but it's not the only thing leading to the development of autism."
The researchers caution, however, that blood oxytocin measurements may be different than oxytocin levels in the cerebrospinal fluid bathing the brain, which they did not measure.
In addition to examining blood oxytocin levels, the researchers examined the importance of small variations in the gene coding for the oxytocin receptor. Certain receptor variants were correlated to higher scores on standard tests of social ability, the study found.
The team also discovered that blood levels of oxytocin are highly heritable: The levels are influenced by inheritance to about the same degree as adult height, which is often described as being strongly influenced by genetics.
"What our study hints at is that social function may be heritable in families," Parker said.
The study will help to guide future research to determine whether oxytocin is a useful autism treatment. The study's findings suggest that some children with autism — such as the subset of kids with autism who have naturally low oxytocin levels, or those with oxytocin receptor gene variants associated with worse social functioning — might benefit most from oxytocin-like drugs.
"Autism is so heterogeneous," Parker said. "If we can identify biomarkers that help us identify the patients most likely to benefit from a specific therapy, we expect that will be very useful."
INFORMATION:
Other Stanford authors of the study are Joseph Garner, PhD, associate professor of comparative medicine; Robin Libove, social science research assistant; Shellie Hyde, laboratory manager; Kirsten Hornbeak, medical student; Dean Carson, PhD, postdoctoral scholar; Chun-Ping Liao, life science research assistant; Jennifer Phillips, PhD, clinical associate professor of psychiatry and behavioral sciences and co-director of the Autism and Developmental Disabilities Clinic at Lucile Packard Children's Hospital Stanford; and Joachim Hallmayer, MD, associate professor of psychiatry and behavioral sciences.
Parker, Hardan, Garner and Hallmayer are members of Stanford's Child Health Research Institute.
The research was supported by grants from the Simons Foundation Autism Research Initiative, the Mosbacher Family Fund for Autism Research, the Escher Fund at the Silicon Valley Community Foundation, Stanford's Child Health Research Institute and the National Institutes of Health (grant RR000167).
Information about Stanford's Department of Psychiatry and Behavioral Sciences, which also supported the work, is available at http://psychiatry.stanford.edu.
Information about ongoing Stanford research in oxytocin therapy for children with autism is available at http://med.stanford.edu/clinicaltrials/trials/NCT01624194. More information about related research can be found at https://web.stanford.edu/group/autism.
The Stanford University School of Medicine consistently ranks among the nation's top medical schools, integrating research, medical education, patient care and community service. For more news about the school, please visit http://mednews.stanford.edu. The medical school is part of Stanford Medicine, which includes Stanford Hospital & Clinics and Lucile Packard Children's Hospital Stanford. For information about all three, please visit http://stanfordmedicine.org/about/news.html.
Stanford Children's Health, with Lucile Packard Children's Hospital Stanford at its core, is an internationally recognized leader in world-class, nurturing care and extraordinary outcomes in every pediatric and obstetric specialty from the routine to rare, for every child and pregnant woman. Together with our Stanford Medicine physicians, nurses, and staff, we deliver this innovative care and research through partnerships, collaborations, outreach, specialty clinics and primary care practices at more than 100 locations in the U.S. western region. As a non-profit, we are committed to supporting our community – from caring for uninsured or underinsured kids, homeless teens and pregnant moms, to helping re-establish school nurse positions in local schools. Learn more about our full range of preeminent programs and network of care at stanfordchildrens.org, and on our Healthier, Happy Lives blog. Join us on Facebook, Twitter, LinkedIn and YouTube.
Lucile Packard Children's Hospital Stanford is the heart of Stanford Children's Health, and is one of the nation's top hospitals for the care of children and expectant mothers. For a decade, we have received the highest specialty rankings of any Northern California children's hospital, according to U.S. News & World Report's 2014-15 Best Children's Hospitals survey, and are the only hospital in Northern California to receive the national 2013 Leapfrog Group Top Children's Hospital award for quality and patient care safety. Discover more at stanfordchildrens.org.
Print media contact: Erin Digitale at (650) 724-9175 (digitale@stanford.edu)
Broadcast media contact: Winter Johnson at (650) 498-7056 (wijohnson@lpch.org)
Blood-oxytocin levels in normal range in children with autism, study finds
2014-08-04
ELSE PRESS RELEASES FROM THIS DATE:
Epidemic outbreaks caused by environment, not evolution
2014-08-04
Researchers have traced genetic changes in a bacterial pathogen over 450 years, and claim that epidemics of bacterial disease in human history may be caused by chance environmental changes rather than genetic mutations.
In a study published in PNAS, a team led by the University of Warwick analysed 149 genomes of Salmonella enterica serovar Paratyphi A, which is a major cause of enteric fever. Enteric fever is currently estimated at 27 million clinical cases each year, resulting in 200,000 deaths.
Lead author, Zhemin Zhou from Warwick Medical School, said: "When epidemics ...
Study traces evolutionary origins of migration in New World birds
2014-08-04
Every year, millions of birds make the journey from North America to Central and South America for the winter. But the evolutionary origins of this long-distance migration have remained opaque due to the complex geographic distributions of modern and ancient bird ranges.
Now, a team of scientists from the University of Chicago have developed a new method to reveal the ancestral ranges of New World birds, and discovered that bird migration in the Americas evolved in species that resided in North America. Their work also offers evidence that many tropical bird species descended ...
Learning how things fall apart
2014-08-04
CAMBRIDGE, Mass. -- Materials that are firmly bonded together with epoxy and other tough adhesives are ubiquitous in modern life — from crowns on teeth to modern composites used in construction. Yet it has proved remarkably difficult to study how these bonds fracture and fail, and how to make them more resistant to such failures.
Now researchers at MIT have found a way to study these bonding failures directly, revealing the crucial role of moisture in setting the stage for failure. Their findings are published in the journal Proceedings of the National Academy of Science ...
Equation to predict happiness
2014-08-04
The happiness of over 18,000 people worldwide has been predicted by a mathematical equation developed by researchers at UCL, with results showing that moment-to-moment happiness reflects not just how well things are going, but whether things are going better than expected.
The new equation accurately predicts exactly how happy people will say they are from moment to moment based on recent events, such as the rewards they receive and the expectations they have during a decision-making task. Scientists found that overall wealth accumulated during the experiment was not ...
Model of viral lifecycle could help in finding a cure for hepatitis B
2014-08-04
CAMBRIDGE, MA -- A new technique for studying the lifecycle of the hepatitis B virus could help researchers develop a cure for the disease.
In a paper published today in the journal Proceedings of the National Academy of Sciences, Sangeeta Bhatia of MIT and Charles Rice of Rockefeller University describe using microfabricated cell cultures to sustain hepatitis B virus in human liver cells, allowing them to study immune responses and drug treatments.
Around 400 million people worldwide are infected with the hepatitis B virus (HBV); of those, one-third will go on to develop ...
Weakness of leukemic stem cells discovered
2014-08-04
FRANKFURT. Despite improved therapy, only one out of every two adult patients survive acute myeloid leukaemia (AML). The mean survival time for this disease, which predominantly occurs in the elderly, is less than a year for patients over 65 years. It is assumed that leukaemic stem cells, which cannot be completely eliminated during treatment, are the origin of relapse. However, as has been discovered by a team of Frankfurt-based researchers, these cells do have a weakness: In the current edition of the high impact journal "Cancer Research", they report that the enzyme ...
Minuscule chips for NMR spectroscopy promise portability, parallelization
2014-08-04
Cambridge, Mass. – August 4, 2014 – A team of engineers at the Harvard School of Engineering and Applied Sciences (SEAS), Schlumberger-Doll Research Center in Cambridge, Mass., and the University of Texas, Austin, have created a truly portable device for nuclear magnetic resonance (NMR) spectroscopy.
NMR spectroscopy is a technique that perturbs protons within a molecule to glean important clues about its structure. It can identify unknown substances, detect very slight variations in chemical composition, and measure how molecules interact, making it an essential tool ...
The evolution of migration
2014-08-04
Each year, millions of birds migrate thousands of miles between the locations where they breed and raise young, and the areas where they spend the winter. Each migration is a trip fraught with danger—many birds die before they reach their final destination. To scientists, long distance migration still holds many mysteries, one of which is: where did migration begin and how did it evolve? This question has long been a debated topic among scientists, but thanks to new research from Field Museum scientists, we may have an answer for one of the largest groups of migratory birds. ...
Flores bones show features of Down syndrome, not a new 'hobbit' human
2014-08-04
In October 2004, excavation of fragmentary skeletal remains from the island of Flores in Indonesia yielded what was called "the most important find in human evolution for 100 years." Its discoverers dubbed the find Homo floresiensis, a name suggesting a previously unknown species of human.
Now detailed reanalysis by an international team of researchers including Robert B. Eckhardt, professor of developmental genetics and evolution at Penn State, Maciej Henneberg, professor of anatomy and pathology at the University of Adelaide, and Kenneth Hsü, a Chinese geologist and ...
Triple therapy revs up immune system against common brain tumor
2014-08-04
A triple therapy for glioblastoma, including two types of immunotherapy and targeted radiation, has significantly prolonged the survival of mice with these brain cancers, according to a new report by scientists at the Johns Hopkins Kimmel Cancer Center.
Mice with implanted, mouse-derived glioblastoma cells lived an average of 67 days after the triple therapy, compared with mice that lasted 24 days when they received only the two immunotherapies. Half of the mice who received the triple therapy lived 100 days or more and were protected against further tumors when new cancer ...